Dr. Hauser joined GeoVax in 2018 as a scientist and has since accepted the role of directing research programs to preclinical endpoint. Mary brings expertise in pathogen host interactions with over 15 years training on the topic. Her prior research in Virology & Immunology at University of Georgia and Virginia Tech Carilion Research Institute involved studies with multiple virus families and addressed key mechanisms viral fitness. Mary’s experience gives distinctive insight into optimal design of prophylactics for infectious diseases. After receiving a BS in Chemistry from University of South Carolina, she obtained a Ph.D. in Microbiology & Immunology from Wake Forest University.